Literature DB >> 18930613

Inhaled nitric oxide in the term newborn.

John P Kinsella1.   

Abstract

Inhaled nitric oxide is a selective pulmonary vasodilator that serves integral diagnostic and therapeutic roles in the clinical management of near-term and term newborns with hypoxemic respiratory failure and pulmonary hypertension. Its proper use and potential limitations in current clinical practice are reviewed.

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18930613     DOI： 10.1016/j.earlhumdev.2008.08.002

Source DB:  PubMed          Journal:  Early Hum Dev        ISSN： 0378-3782            Impact factor:   2.079


  5 in total

1.  [Early risk factors for death in neonates with persistent pulmonary hypertension of the newborn treated with inhaled nitric oxide].

Authors:  Ai-Min Qian; Wen Zhu; Yang Yang; Ke-Yu Lu; Jia-Li Wang; Xu Chen; Chu-Chu Guo; Ya-Dong Lu; Hui Rong; Rui Chneg
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2022-05-15

2.  A pumpless lung assist device reduces mechanical ventilation-induced lung injury in juvenile piglets.

Authors:  George T El-Ferzli; Joseph B Philips; Arlene Bulger; Namasivayam Ambalavanan
Journal:  Pediatr Res       Date:  2009-12       Impact factor: 3.756

Review 3.  Current Concepts in the Management of Congenital Diaphragmatic Hernia in Infants.

Authors:  Vasanth H S Kumar
Journal:  Indian J Surg       Date:  2015-05-30       Impact factor: 0.656

Review 4.  The pulmonary circulation in neonatal respiratory failure.

Authors:  Satyan Lakshminrusimha
Journal:  Clin Perinatol       Date:  2012-09       Impact factor: 3.430

Review 5.  Congenital Diaphragmatic hernia - a review.

Authors:  Praveen Kumar Chandrasekharan; Munmun Rawat; Rajeshwari Madappa; David H Rothstein; Satyan Lakshminrusimha
Journal:  Matern Health Neonatol Perinatol       Date:  2017-03-11
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.